OPEN END TURBO OPTIONSSCHEIN SHORT - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 12:31:11 24/05/2024 pm IST | ||
| 0.82 EUR | +18.84% |
|
| Current month | -25.00% | ||
| 1 month | -41.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 0.82 | +18.84% |
| 23/24/23 | 0.69 | +15.19% |
| 22/24/22 | 0.599 | +12.17% |
| 21/24/21 | 0.534 | +31.20% |
| 20/24/20 | 0.407 | -26.00% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 12:31 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GQ98AA |
| ISIN | DE000GQ98AA2 |
| Date issued | 16/11/2023 |
| Strike | 148.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.29 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.45 € |
|---|---|
| Lowest since issue | 0.407 € |
| Spread | 0.05 € |
| Spread % | 5.75% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140
USD
Average target price
146.8
USD
Spread / Average Target
+4.83%
- Stock Market
- Certificates
- Certificat
